Jill Davies

Emailjill.davieslstmed.acuk

Fingerprint

Dive into the research topics where Jill Davies is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

32 Article
3 Other contribution
2 Comment/debate
1 Letter

Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function
Craig, A., Storm, J., Wu, Y., Davies, J. & Moxon, C. A., 19 Feb 2020, In: Wellcome Open Research. 5, 34.
Research output: Contribution to journal › Article › peer-review

Open Access
File
10 Citations (Scopus)
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
Aljayyoussi, G., Tyrer, H., Ford, L., Sjoberg, H., Pionnier, N., Waterhouse, D., Davies, J., Gamble, J., Metuge, H., Cook, D., Steven, A., Sharma, R., Guimaraes, A., Clare, R., Cassidy, A., Johnston, K., Myhill, L., Hayward, L., Wanji, S. & Turner, J. & 2 others, Taylor, M. & Ward, S., 18 Jan 2018
Research output: Other contribution › peer-review

Open Access
File
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.
Sharma, R., Aljayyoussi, G., Tyrer, H. E., Gamble, J., Hayward, L., Guimaraes, A. F., Davies, J., Waterhouse, D., Cook, D. A. N., Myhill, L. J., Clare, R., Cassidy, A., Steven, A., Johnston, K., Ford, L., Turner, J., Ward, S. & Taylor, M., 8 Jan 2018, 1 p.
Research output: Other contribution

Open Access
File
3 Citations (Scopus)
Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties
David Hong, W., Leung, S. C., Amporndanai, K., Davies, J., Priestley, R. S., Nixon, G. L., Berry, N. G., Samar Hasnain, S., Antonyuk, S., Ward, S., Biagini, G. & O'Neill, P. M., 19 Oct 2018, In: ACS Medicinal Chemistry Letters. 9, 12, p. 1205-1210 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
32 Citations (Scopus)
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malaria.
O’ Neill, P. M., Stocks, P. A., Sabbani, S., Roberts, N. L., Amewu, R. K., Shore, E. R., Aljayyoussi, G., Angulo-Barturén, I., Belén, M., Jiménez-Díaz, Bazaga, S. F., Martínez, M. S., Campo, B., Sharma, R., Charman, S. A., Ryan, E., Chen, G., Shackleford, D. M., Davies, J. & Nixon, G. L. & 2 others, Biagini, G. & Ward, S., 15 Jul 2018, In: Bioorganic and Medicinal Chemistry. 26, 11, p. 2996-3005 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
16 Citations (Scopus)

Mrs Jill Davies

Fingerprint

Research output

Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function

Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.

Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.

Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties

Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malaria.